Fast Five Quiz: Tardive Dyskinesia Management

Authors and Disclosures

Author(s)

Christoph U. Correll, MD

Professor of Psychiatry, Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Medical Director, Recognition and Prevention Program, Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York

Disclosure: Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Acadia; Alkermes, Inc.; Allergan, Inc.; Angelini Pharma US; Axsome; Gedeon Richter; Intra-Cellular Therapies, Inc; Janssen/Johnson & Johnson; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C. LB Pharma; Lundbeck, Inc.;
Serve(d) as a speaker or a member of a speakers bureau for: Allergan; Angelini; Gedeon Richter; Janssen/Johnson & Johnson; Lundbeck, Inc.; Mylan; Otsuka; Recordati; Rovi; Sumitomo Dainippon; Sunovion
Received research grant from: Janssen; Takeda
Received income in an amount equal to or greater than $250 from: Acadia; Alkermes, Inc.; Allergan, Inc.; Angelini Pharma US; Axsome; Gedeon Richter; Intra-Cellular Therapies, Inc; Janssen/Johnson & Johnson; Kukuna; LB Pharma; Lundbeck, Inc.